Endogenous bone morphogenetic proteins mediate 1α, 25-dihydroxyvitamin D3-induced expression of osteoblast differentiation markers in human dermal fibroblasts

Journal of Orthopaedic Research

Volumn 27, Issue 2, 2009, Pages 162-168

  Hee, Christopher K ^a   Nicoll, Steven B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone morphogenetic protein; Dermal fibroblast; Gene expression; Osteoblast; Vitamin D3

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CALCITRIOL; CELL MARKER; NEUTRALIZING ANTIBODY; NOGGIN; OSTEOCALCIN; ANTIBODY; BIOLOGICAL MARKER; BMP4 PROTEIN, HUMAN; BMP6 PROTEIN, HUMAN; BONE DENSITY CONSERVATION AGENT;

ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG INHIBITION; ENZYME ACTIVITY; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOBLAST; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; CELL CULTURE; CELL LINEAGE; CYTOLOGY; DERMIS; DRUG EFFECT; FIBROBLAST; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CALCITRIOL; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DERMIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION; HUMANS; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 59449097475     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20728     Document Type: Article

References (36)

1. Hirata K, Tsukazaki T, Kadowaki A, et al. 2003. Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 32:502-512.
2. Krebsbach PH, Gu K, Franceschi RT, et al. 2000. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 11:1201-1210.
3. Franceschi RT, Wang D, Krebsbach PH, et al. 2000. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 78:476-486.
4. Rutherford RB, Moalli M, Franceschi RT, et al. 2002. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng 8:441-452.
5. Rutherford R, Gu K, Racenis P, et al. 2003. Early events: the in vitro conversion of BMP transduced fibroblasts to chondroblasts. Connect Tiss Res 44:117-123.
6. 3 and dexamethasone in vitro. J Cell Physiol 193:164-172.
7. Hee CK, Jonikas MA, Nicoll SB. 2006. Influence of three-dimensional scaffold on the expression of osteogenic differentiation markers by human dermal fibroblasts. Biomaterials 27:875-884.
8. 3. Proc Natl Acad Sci USA 86:4455-4459.
9. Ozono K, Liao J, Kerner S, et al. 1990. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 265:21881-21888.
10. 3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 39:941-947.
11. 3, β-glycerophosphate, and ascorbic acid. Biochem Biophys Res Comm 362:17-24.
12. Reddi AH. 1992. Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol 4:850-855.
13. Wozney J. 2002. Overview of bone morphogenetic proteins. Spine 27:S2-S8.
14. Virdi AS, Cook LJ, Oreffo ROC, et al. 1998. Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines. Cell Mol Biol 44:1237-1246.
15. 3 on bone morphogenetic protein-3 mRNA expression. J Cell Biochem 73:11-19.
16. 3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 16:1243-1256.
17. Swami S, Raghavachari N, Muller UR, et al. 2003. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 80:49-62.
18. 3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. J Steroid Biochem Mol Biol 92:131-141.
19. Lee HJ, Wislocki A, Goodman C, et al. 2006. A novel vitamin D derivative activates bone morphogenetic protein signaling in MCF10 breast epithelial cells. Mol Pharmacol 69:1840-1848.
20. Lee HJ, Liu H, Goodman C, et al. 2006. Gene expression profiling changes induced by a novel Gemini vitamin D derivative during the progression of breast cancer. Biochem Pharmacol 72:332-343.
21. 3 target genes. Mol Endocrinol 19:2685-2695.
22. Lossos IS, Czerwinski DK, Wechser MA, et al. 2003. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 17:789-795.
23. Singer VL, Jones LJ, Yue ST, et al. 1997. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal Biochem 249:228-238.
24. Ducy P, Zhang R, Geoffroy V, et al. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
25. Owen TA, Aronow MS, Barone LM, et al. 1991. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128:1496-1504.
26. Lian JB, Stein GS. 1993. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGFBeta1) and hormones (vitamin D and glucocorticoids). J Oral Implantol 19:95-105.
27. Xiao ZS, Thomas R, Hinson TK, et al. 1998. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214:187-197.
28. 3 suppresses the bone-related runx2/cbfa1 gene promoter. Exp Cell Res 274:323-333.
29. 3, dexamethasone, and local growth factors in primary human osteoblasts. J Cell Biochem 86:348-356.
30. Pockwinse SM, Stein JL, Lian JB, et al. 1995. Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: interrelationship of morphology and gene expression by in situ hybridization. Exp Cell Res 216:244-260.
31. Lian JB, Stein GS, Canalis E, et al. 1999. Bone formation: osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th ed. Philadelphia: Lippincott, Williams & Wilkins. p 14-29.
32. Bodine PVN, Komm BS. 2002. Tissue culture models for studies of hormone and vitamin action in bone cells. Vitam Horm 64:101-151.
33. Zimmerman LB, De Jesus-Escobar JM, Harland RM. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606.
34. Groppe J, Greenwald J, Wiater E, et al. 2002. Structural basis of BMP signaling inhibition by the cysteine knot protein noggin. Nature 420:636-642.
35. Canalis E, Economides AN, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235.
36. Abe E. 2006. Function of BMPs and BMP antagonists in adult bone. Ann NY Acad Sci 1068:41-53.